Zur Kurzanzeige

2010-03-17Zeitschriftenartikel DOI: 10.1017/S0950268810000543
Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003–2006
dc.contributor.authorJorgensen, Pernille
dc.contributor.authorPoethko-Müller, Christina
dc.contributor.authorHellenbrand, Wiebke
dc.contributor.authorJilg, Wolfgang
dc.contributor.authorThierfelder, Wulf
dc.contributor.authorMeyer, Christiane
dc.contributor.authorHeiden, Matthias an der
dc.contributor.authorSchlaud, Martin
dc.contributor.authorRadun, Doris
dc.date.accessioned2018-05-07T14:29:34Z
dc.date.available2018-05-07T14:29:34Z
dc.date.created2011-03-17
dc.date.issued2010-03-17none
dc.identifier.otherhttp://edoc.rki.de/oa/articles/remnAa0qzk0dk/PDF/234pDgu0ELeP.pdf
dc.identifier.urihttp://edoc.rki.de/176904/838
dc.description.abstractThe success of childhood vaccination against hepatitis B relies on persistence of immunity into adolescence and adulthood. In 2000, two hexavalent vaccines with a hepatitis B component (Hexavac®, Infanrix hexa®) were introduced in Germany. Hexavac was withdrawn in 2005 amidst concerns about its long-term hepatitis B protection. We compared hepatitis B surface antibody (anti-HBs) levels in children fully vaccinated with Hexavac or Infanrix hexa (n=477) in a secondary data analysis of a large cross-sectional health survey in Germany. On average 2·4 years after vaccination, 25·3% of Hexavac vaccinees had anti-HBs levelseng
dc.language.isoeng
dc.publisherRobert Koch-Institut, Infektionsepidemiologie
dc.subjectHepatitis Beng
dc.subjectpublic healtheng
dc.subjectvaccination (immunization)eng
dc.subjectvaccineseng
dc.subject.ddc610 Medizin
dc.titleLow hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: results of the German Health Survey for Children and Adolescents, 2003–2006
dc.typeperiodicalPart
dc.identifier.urnurn:nbn:de:0257-10012886
dc.identifier.doi10.1017/S0950268810000543
dc.identifier.doihttp://dx.doi.org/10.25646/763
local.edoc.container-titleEpidemiology and Infection
local.edoc.container-textJorgensen, P., Poethko-Muj̈ller, C., Hellenbrand, W., Jilg, W., Thierfelder, W., Meyer, C., Heiden, M.A.D., Schlaud, M., Radun, D. Low hepatitis B immunogenicity of a hexavalent vaccine widely used in Germany: Results of the German Health Survey for Children and Adolescents, 2003-2006 (2010) Epidemiology and Infection, 138 (11), pp. 1621-1629.
local.edoc.fp-subtypeArtikel
local.edoc.type-nameZeitschriftenartikel
local.edoc.container-typeperiodical
local.edoc.container-type-nameZeitschrift
local.edoc.container-urlhttp://journals.cambridge.org/action/displayAbstract?fromPage=online&aid=7884086
local.edoc.container-publisher-nameCambridge University Press
local.edoc.container-volume138
local.edoc.container-issue11
local.edoc.container-year2010

Zur Kurzanzeige